Nucliq Biologics
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$760,000
Company Overview
Nucliq Biologics is a biotechnology company that develops microbiome-based personalized therapeutics, diagnostics, and at-home testing kits using microbiome science and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Medical Devices, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Data as a Service, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucliq Biologics Comps
Public and private peers based on sector, stage, and business model.
Nucliq Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 24, 2025 | ||||
| Grant | Jan 17, 2024 | ||||
| Grant | Jun 16, 2020 |
Nucliq Biologics Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2025
Monthly visitors increased 67% MoM.
- Jun 1, 2025
Monthly visitors increased 65% MoM.
Nucliq Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nucliq Biologics's valuation, stock price, and market status.
